access to glp 1 medications New Medicare GLP-1 Bridge Program Launching July 1, 2026 Medicare is expanding access to

"Ozempic has become a leading, trusted brand for people with type 2 diabetes and the science is deep

Earlier studies have found that combination therapy with an SGLT2 inhibitor and a GLP-1 RA, compared with monotherapy with either drug alone, is associated with improved control of cardiovascular risk factors, including a greater reduction of HbA 1c , BP and body weight, demonstrating additive effects [16,17,18]

In this blog, we'll explore the effects of creatine supplementation, why the scale might be fickle, and what you can do to stay on top of your weight

Additionally, AI supports microbiome-centered strategies, which are gaining traction in regenerative medicine

Pair with Liposomal Vitamin C for synergistic antioxidant and glutathione recycling support.*

However, combining them should only be done under the supervision of a licensed provider